SSU Institutional Biosafety Committee (IBC)

Governing Regulations:

In accordance with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, Savannah State University (SSU) has established an Institutional Biosafety Committee (IBC).

Purpose/Mission:

The mission of the SSU IBC is to oversee and monitor the control of biohazards associated with the use of microbiological agents and their vectors and to thereby protect the interests of the SSU community with respect to public health and protection of the environment.

The IBC is responsible for overseeing SSU projects that involve, but are not limited to, recombinant DNA, RNAi, pathogens, human materials and other potentially infectious material, as well as transgenic animals.

Protocol for SSU IBC Review & Approval:

All faculty at SSU who conduct projects involving recombinant DNA, RNAi, pathogens, human materials, and other potentially infectious material are required to obtain approval from the SSU IBC prior to initiating their projects.

The SSU Institutional Biosafety Committee reviews and approves these requests to use biohazardous chemicals and materials in research, approves handling and waste disposal protocols, and assesses risks to laboratory workers.

For more information or to submit an application for IBC approval, please contact the SSU IBC chair, Dr. Takayuki Nitta, (912) 358-4459, nittat@savannahstate.edu.